Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report)’s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.27 and traded as high as $0.79. Mesoblast shares last traded at $0.79, with a volume of 100 shares traded.
Mesoblast Stock Up 3.9 %
The firm has a 50 day simple moving average of $0.41 and a two-hundred day simple moving average of $0.27.
Mesoblast Company Profile
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Read More
- Five stocks we like better than Mesoblast
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Investing In Preferred Stock vs. Common Stock
- 3 Value Stocks You Can Buy Before They Become Big
- Investing in the High PE Growth Stocks
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.